chr7-18954247-C-T

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1

The ENST00000432645.6(HDAC9):​c.3030C>T​(p.Phe1010Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.76 in 1,368,696 control chromosomes in the GnomAD database, including 395,978 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.77 ( 45700 hom., cov: 32)
Exomes 𝑓: 0.76 ( 350278 hom. )

Consequence

HDAC9
ENST00000432645.6 synonymous

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.337

Publications

17 publications found
Variant links:
Genes affected
HDAC9 (HGNC:14065): (histone deacetylase 9) Histones play a critical role in transcriptional regulation, cell cycle progression, and developmental events. Histone acetylation/deacetylation alters chromosome structure and affects transcription factor access to DNA. The protein encoded by this gene has sequence homology to members of the histone deacetylase family. This gene is orthologous to the Xenopus and mouse MITR genes. The MITR protein lacks the histone deacetylase catalytic domain. It represses MEF2 activity through recruitment of multicomponent corepressor complexes that include CtBP and HDACs. This encoded protein may play a role in hematopoiesis. Multiple alternatively spliced transcripts have been described for this gene but the full-length nature of some of them has not been determined. [provided by RefSeq, Jul 2008]
HDAC9 Gene-Disease associations (from GenCC):
  • auriculocondylar syndrome 4
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 7-18954247-C-T is Benign according to our data. Variant chr7-18954247-C-T is described in ClinVar as Benign. ClinVar VariationId is 402925.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=0.337 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.802 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000432645.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HDAC9
NM_178425.4
MANE Select
c.3022+17C>T
intron
N/ANP_848512.1
HDAC9
NM_058176.2
c.3030C>Tp.Phe1010Phe
synonymous
Exon 23 of 23NP_478056.1
HDAC9
NM_178423.3
c.3013+17C>T
intron
N/ANP_848510.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HDAC9
ENST00000432645.6
TSL:1
c.3030C>Tp.Phe1010Phe
synonymous
Exon 23 of 23ENSP00000410337.2
HDAC9
ENST00000686413.1
MANE Select
c.3022+17C>T
intron
N/AENSP00000509161.1
HDAC9
ENST00000441542.7
TSL:1
c.3022+17C>T
intron
N/AENSP00000408617.2

Frequencies

GnomAD3 genomes
AF:
0.775
AC:
117682
AN:
151872
Hom.:
45654
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.809
Gnomad AMI
AF:
0.702
Gnomad AMR
AF:
0.809
Gnomad ASJ
AF:
0.767
Gnomad EAS
AF:
0.715
Gnomad SAS
AF:
0.780
Gnomad FIN
AF:
0.765
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.754
Gnomad OTH
AF:
0.762
GnomAD2 exomes
AF:
0.776
AC:
122720
AN:
158116
AF XY:
0.774
show subpopulations
Gnomad AFR exome
AF:
0.805
Gnomad AMR exome
AF:
0.872
Gnomad ASJ exome
AF:
0.772
Gnomad EAS exome
AF:
0.713
Gnomad FIN exome
AF:
0.761
Gnomad NFE exome
AF:
0.752
Gnomad OTH exome
AF:
0.758
GnomAD4 exome
AF:
0.758
AC:
921878
AN:
1216708
Hom.:
350278
Cov.:
18
AF XY:
0.759
AC XY:
461809
AN XY:
608528
show subpopulations
African (AFR)
AF:
0.802
AC:
22187
AN:
27674
American (AMR)
AF:
0.862
AC:
29881
AN:
34662
Ashkenazi Jewish (ASJ)
AF:
0.779
AC:
18614
AN:
23894
East Asian (EAS)
AF:
0.704
AC:
24839
AN:
35302
South Asian (SAS)
AF:
0.782
AC:
57631
AN:
73702
European-Finnish (FIN)
AF:
0.759
AC:
37582
AN:
49508
Middle Eastern (MID)
AF:
0.736
AC:
3709
AN:
5038
European-Non Finnish (NFE)
AF:
0.752
AC:
687972
AN:
915012
Other (OTH)
AF:
0.760
AC:
39463
AN:
51916
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
10545
21091
31636
42182
52727
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15806
31612
47418
63224
79030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.775
AC:
117786
AN:
151988
Hom.:
45700
Cov.:
32
AF XY:
0.778
AC XY:
57762
AN XY:
74286
show subpopulations
African (AFR)
AF:
0.809
AC:
33565
AN:
41494
American (AMR)
AF:
0.809
AC:
12323
AN:
15228
Ashkenazi Jewish (ASJ)
AF:
0.767
AC:
2660
AN:
3470
East Asian (EAS)
AF:
0.715
AC:
3685
AN:
5154
South Asian (SAS)
AF:
0.779
AC:
3756
AN:
4822
European-Finnish (FIN)
AF:
0.765
AC:
8084
AN:
10562
Middle Eastern (MID)
AF:
0.759
AC:
223
AN:
294
European-Non Finnish (NFE)
AF:
0.754
AC:
51239
AN:
67946
Other (OTH)
AF:
0.765
AC:
1612
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1369
2738
4108
5477
6846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.764
Hom.:
28343
Bravo
AF:
0.778
Asia WGS
AF:
0.761
AC:
2636
AN:
3466

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
2.4
DANN
Benign
0.63
PhyloP100
0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2389998; hg19: chr7-18993870; COSMIC: COSV67786182; COSMIC: COSV67786182; API